Log in

NASDAQ:BPMCBlueprint Medicines Price Target & Analyst Ratings

+0.13 (+0.16 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $79.15
50-Day Range
MA: $70.62
52-Week Range
Now: $79.15
Volume265,494 shs
Average Volume767,645 shs
Market Capitalization$4.29 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Blueprint Medicines (NASDAQ:BPMC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
13 Wall Street analysts have issued ratings and price targets for Blueprint Medicines in the last 12 months. Their average twelve-month price target is $95.67, suggesting that the stock has a possible upside of 20.87%. The high price target for BPMC is $122.00 and the low price target for BPMC is $59.00. There are currently 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.922.923.002.91
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
10 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
11 Buy Rating(s)
1 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
1 Strong Buy Rating(s)
Consensus Price Target: $95.67$91.42$105.75$104.20
Price Target Upside: 20.87% upside55.02% upside94.04% upside31.10% upside

Blueprint Medicines (NASDAQ:BPMC) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Blueprint Medicines (NASDAQ:BPMC) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/8/2020Deutsche BankBoost Price TargetPositive ➝ Buy$70.00 ➝ $85.00High
6/8/2020BMO Capital MarketsBoost Price TargetOutperform$75.00 ➝ $111.00High
5/7/2020HC WainwrightReiterated RatingBuy$66.00Medium
5/4/2020BarclaysInitiated CoverageEqual Weight$59.00Low
4/30/2020Canaccord GenuityLower Price TargetBuy$115.00 ➝ $100.00Low
4/30/2020Morgan StanleyLower Price TargetOverweight$103.00 ➝ $88.00Low
4/29/2020JMP SecuritiesLower Price TargetMarket Outperform$107.00 ➝ $103.00Medium
4/29/2020SVB LeerinkLower Price TargetOutperform$125.00 ➝ $105.00Medium
3/24/2020WedbushReiterated RatingOutperformHigh
3/16/2020CowenInitiated CoverageBuyHigh
12/20/2019Piper Jaffray CompaniesLower Price TargetNeutral$85.00 ➝ $77.00Low
11/6/2019Raymond JamesUpgradeOutperform ➝ Strong-Buy$106.00 ➝ $112.00Medium
7/18/2019Robert W. BairdInitiated CoverageOutperform$120.00Medium
5/23/2019Goldman Sachs GroupReiterated RatingBuy ➝ Buy$125.00High
9/18/2018GuggenheimInitiated CoverageBuy$102.00High
9/29/2017DA DavidsonInitiated CoverageBuy$90.00High
9/29/2017BTIG ResearchInitiated CoverageBuy ➝ Buy$90.00High
9/5/2017Jefferies Financial GroupReiterated RatingBuy$56.00Medium
(Data available from 7/3/2018 forward)
This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.